Medicines that are used in the treatment of heart disease, cancer, and certain mental disorders are currently not selective, and when used, trigger both the desired therapeutical effects and adverse effects. We have developed compounds that have greater selectivity and efficacy, so that their use may lead to an increase in the therapeutic effect and a considerable decrease in adverse effects.